English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2537186      線上人數 : 238
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋


    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/56997


    題名: 褪黑激素治療腎細胞癌轉移之臨床前研究
    The Therapeutic Potential of Melatonin on Renal Carcinoma Cell Metastasis - A Preclinical Study
    作者: 林雍偉
    Lin, Yung-Wei
    貢獻者: 臨床醫學研究所
    關鍵詞: Akt;褪黑激素;轉移;基質金屬蛋白酶;核因子活化B細胞κ輕鏈增強子;腎細胞癌
    Akt;melatonin;metastasis;MMPs;NF-κB;renal cell carcinoma
    日期: 2018
    上傳時間: 2018-12-28 12:40:41 (UTC+8)
    摘要: 腎細胞癌時常發生鄰近器官侵犯甚至遠處轉移，因此在所有泌尿系統惡性腫瘤中最容易引發癌症相關死亡。褪黑激素因可以調控生理時鐘，具有直接或間接清除自由基，抑制正常細胞凋亡等生理活性外，同時具有多種抑制腫瘤活性，例如對抗腫瘤增殖、誘發細胞凋亡，抗血管生成及免疫調控的作用。先前研究發現褪黑激素可以抑制肝癌細胞，骨肉瘤細胞，及神經膠質瘤細胞的侵犯能力，也有研究報告指出褪黑激素可以促進咖啡白脂或直接抑制腎癌細胞增生，然而褪黑激素在腎細胞癌抗腫瘤轉移的能力及機制尚不清楚。在此研究中，我們證明褪黑激素在藥物濃度(0.5-2 mM)能有效的減少腎細胞癌細胞（Caki-1 和Achn）的遷移和侵襲的能力。此外我們發現在原位性和實驗性轉移動物模式中褪黑激素能抑制Caki-1腎癌細胞轉移。進一步探討褪黑激素抑制的機制顯示，褪黑激素能減少基質金屬蛋白酶-9(MMP-9)的生合成是透過抑制基因轉錄，而此作用經實驗證實，主要是而減少轉錄因子NF-κB與啟動子間的結合，而NF-κB家族中的p65和p52蛋白與MMP-9染色體的結合能力及細胞核的移位最為重要。除此之外，Akt主導絲裂原活化蛋白激酶MAPK中JNK1/2和ERK1/2的訊息路徑參與褪黑激素調控基質金屬蛋白酶-9基因啟動和細胞運動。基因資料庫顯示褪黑激素受體1A(MTNR1A)與MMP-9基因在正常腎臟組織及腎細胞癌腫瘤組織中的表現呈負相關性。並且發現在腎細胞癌患者基因表現MTNR1A高/MMP-9低比MTNR1A低/MMP-9高的患者有較高的存活率。總體而言，我們的研究結果提供的新的觀點在褪黑激素抑制抑制腎癌細胞轉移的調控，並提供褪黑激素潛在的治療應用在轉移型腎細胞癌。
    Renal cell carcinoma (RCC) causes most cancer death among urologic malignancy because of its metastatic potential to vital organs. Melatonin own multiple oncostatic activities through tumor growth inhibition, induction of apoptosis, and anti-angiogenic actions in various cancers. However, the anti-metastatic activity of melatonin and its mechanism in RCC are poorly elucidated. In this study, we revealed that the pharmacologic concentration (0.5–2 mM) of melatonin inhibited the migration and invasion of RCC cells (Caki-1 and Achn). Furthermore, we demonstrated that melatonin suppressed tumor growth and metastasis of Caki-1 cells in orthotopic and experimental metastatic animal models. Further investigations revealed that melatonin inhibited matrix metalloproteinase-9 (MMP-9) transcription by reducing p65- and p52-DNA-binding activities and nucleus translocation. Moreover, the Akt-mediated mitogen-activated protein kinase (MAPK) signaling pathways were participated in melatonin-regulated MMP-9 transactivation and cancer cell motility in RCC. According to The Cancer Genome Atlas database, there was an inverse correlation between melatonin receptor 1A (MTNR1A) and MMP-9 expression in normal kidney and RCC tissues. Furthermore, a higher survival rate was found in MTNR1Ahigh/MMP-9low patients than in MTNR1Alow/MMP-9high patients. In summary, this study provide new insights into the role of melatonin-mediated regulation in suppressing RCC metastasis and suggest that melatonin has potential therapeutic applications for metastatic RCC.
    描述: 博士
    指導教授：簡銘賢
    資料類型: thesis
    顯示於類別:[臨床醫學研究所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML209檢視/開啟


    檢視Licence

    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice

    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏，包含體系內各式學術著作及學術產出。秉持開放取用的精神，提供使用者進行資料檢索、下載與取用，惟仍請適度、合理地於合法範圍內使用本平台之內容，以尊重著作權人之權益。商業上之利用，請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台，視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例，並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者，煩請權利人通知本平台維護人員([email protected])，將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋